Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome

Citation
A. Lacroix et al., Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome, ENDOCR REV, 22(1), 2001, pp. 75-110
Citations number
404
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINE REVIEWS
ISSN journal
0163769X → ACNP
Volume
22
Issue
1
Year of publication
2001
Pages
75 - 110
Database
ISI
SICI code
0163-769X(200102)22:1<75:EAAHRI>2.0.ZU;2-9
Abstract
The mechanism by which cortisol is produced in adrenal Gushing's syndrome, when ACTH is suppressed, was previously unknown and was referred to as bein g "autonomous." More recently, several investigators have shown that some c ortisol and other steroid-producing adrenal tumors or hyperplasias are unde r the control of ectopic (or aberrant, illicit, inappropriate) membrane hor mone receptors. These include ectopic receptors for gastric inhibitory poly peptide (GIP), beta -adrenergic agonists, or LH/hCG; a similar outcome can result from altered activity of eutopic receptors, such as those for vasopr essin (V1-AVPR), serotonin (5-HT4), or possibly leptin. The presence of abe rrant receptors places adrenal cells under stimulation by a trophic factor not negatively regulated by glucocorticoids, leading to increased steroidog enesis and possibly to the proliferative phenotype. The molecular mechanism s responsible for the abnormal expression and function of membrane hormone receptors are still largely unknown. Identification of the presence of thes e illicit receptors can eventually lead to new pharmacological therapies as alternatives to adrenalectomy, now demonstrated by the long-term control o f ectopic beta -AR- and LH/hCGR-dependent Gushing's syndrome by propanolol and leuprolide acetate. Further studies will potentially identify a larger diversity of hormone receptors capable of coupling to G proteins, adenylyl cyclase, and steroidogenesis in functional adrenal tumors and probably in o ther endocrine and nonendocrine tumors.